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ABSTRACT
Ferulic acid, a well-known natural phenolic compound, is considerably reported
for its hydroxyl and peroxyl radical scavenging activities. However, the antiox-
idant capacity of ferulic acid is limited by its relatively low solubility in hydro-
phobicmedia thereby preventing its application for autoxidation of fats and oils.
To this end, several research efforts are beingmade tomaximize the therapeutic
benefits of ferulic acid and these efforts included but not limited to structural
modification of ferulic acid to produce its derivatives. In this study, we synthe-
sized ester and amide derivatives of ferulic acid and evaluated them for in vitro
antioxidant potential as well asmolecular docking properties. Data revealed that
ferulic ester and amide derivatives had excellent antioxidant capacity and
demonstrated strong inhibitory potential. Analysis of molecular docking indi-
cated ferulic ester as potent inhibitor of target proteins in breast cancer aswell as
in oxidative stress. Taken together, the findings support potent antioxidant
properties by these ferulic derivatives. Findings may become relevant where
structural modification to enhance physico-chemical properties without com-
promising the antioxidant and/or medicinal potential are desirable.
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Ferulic acid (FA) is a phenolic compound with excellent antioxidant potential.[1,2] FA is one of the most
abundant phenolic acids found in plants, and in many staple foods, such as fruits, vegetables, cereals, and
coffee.[3,4] The antioxidant potential of FA has been explored for several therapeutic applications, and
wide spectrum of beneficial activity for human health has been advocated for this phenolic compound, at
least in part, because of its strong antioxidant activity.[5,6] It possesses antioxidant property by virtue of its
phenolic hydroxyl group in its structure. The hydroxy and phenoxy groups of FA donate electrons to
quench the free radicals. The presence of electron donating groups on the benzene ring (3-methoxy and
more importantly, 4-hydroxyl) of FA gives the additional property of terminating free radical chain
reactions. Another functional group in the FA, i.e., the carboxylic acid groupwith an adjacent unsaturated
C-C double bond, can provide additional attack sites for free radicals, and thus, prevent them from
attacking the membrane. In addition, this carboxylic acid group also acts as anchor of FA by which it
binds to the lipid bilayer, providing some protection against lipid peroxidation.[7] FA is considerably
reported for its hydroxyl and peroxyl radicals scavenging activity in both brain cells andmacrophages as a
result of its ability to easily form resonance-stabilized phenoxy radical. Its antioxidant potential is however
limited by its relatively low solubility in hydrophobic media which thus prevents its application for the
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autoxidation of fats and oils,[8–11] it is therefore necessary and stimulating to investigate the antioxidant
potentials of synthesized FA derivatives which are most likely to be soluble in hydrophobic environment.
For example, many studies reported that amide derivatives of FA acid enhance insulin secretion,
prevent oxidation of low density lipoprotein, as well as inhibit the cyclooxygenase COX-2-induced
inflammatory diseases.[12,13] In addition, several other investigations have demonstrated better physico-
chemical and antioxidant property by FA derivatives.[14,15] These studies revealed that FA derivatives
possess diverse potentials, such as anticancer,[16,17] antiatherogenic,[18] anticarcinogenic,[19] and anti-
bacterial agents,[20] as well as anti-inflammatory activity.[21,22] Further, several FA derivatives have been
shown to be more lipophilic, thus increasing the ability of the derivatives to cross lipid-rich cell
membranes and thereby offer better antioxidant potential.[23–28]
In light of the aforementioned, we therefore studied structurally modified FA ester and amide
derivatives and comparatively evaluated their in vitro antioxidant potentials as well as their possible
protein binding interactions, using computational docking studies.
Materials and methods
General experimental
All chemical reagents used were of analytical grade and obtained from Sigma (St Louis, MO, USA)
unless otherwise stated. IR spectra were recorded on Shimadzu (8400S) Fourier Transform-Infrared
using KBr pellet. 1H-NMR (300 MHz) and 13C-NMR (75 MHz) spectra were recorded in CDCl3 or
MeOD on Bruker 300 spectrometer. Absorbance measurements were taken on an UV/Vis (Jenway)
Spectrophotometer. Chemical shifts are expressed in parts per million downfield from tetramethyl-
silane as an internal standard. Mass spectra were taken on JMS spectrometer (ESI+) ion trap LCQ,
and thermoelectron corporation. Chromatography was carried out on a gravity column packed with
silica gel as the stationary phase. Thin layer chromatography was performed on 0.2 mm pre-coated
plates of silica gel 60F-264 (Merck), and spots were visualized using an ultraviolet-light lamp.
Synthesis of FA derivatives
FA syringaldehyde ester (compound 1)
FA (2.0 g, 10 mmol) and syringaldehyde (3.0 g, 16 mmol) with 2 drops of sulfuric acid were refluxed
in 40 ml of DMSO for 3 h. The progress of the reaction was monitored by thin layer chromato-
graphy, and it was stopped when there was no sign of any further reaction taking place. The resulting
mixture was chromatographed on silica gel (hexane-dichloromethane, 1:1) and this yielded 3.2 g of
compound 1 (Fig. 1): (E)-4-formyl-2,6-dimethoxyphenyl 3-(4-hydroxy-3-methoxyphenyl)acrylate.
Brown liquid (Yield: 87%). IR (KBr): vmax (cm
−1) 3450 (OH), 3005 (Ar C-H), 2958–2858 (CH),
1693 (C = O), 1593 (C = C), 1236 (C-O). 1H NMR (300 MHz, CDCl3): δH 9.87 (s, 1H), 7.83 (d, 1H),
7.24 (s, 1H), 7.24 (s, 1H), 7.13 (s, 1H), 6.95 (s, 1H), 6.87 (d, 1H), 6.87 (s, 1H), 6.76 (d, 1H), 5.23
(ArOH), 3.92 (s,3H, OCH3), 3.89 (s, 6H, 2 OCH3). 13 C NMR (75 MHz, CDCl3): δC 191.1, 154.4,
146.8, 146.7, 145.9, 144.9, 140.1, 137.9, 137.8, 136.8, 126.4, 120.4, 120.2, 114.6, 114.1, 111.7, 56.3, 56.0,
55.9. ESI-MS; m/z: 376.86 (M + 18) + observed for C19H18O7.
FA urethane amide (compound 2)
FA (5.0 g, 25mmol) and urethane (10.0 g, 112mmol) with catalytic amount of imidazole were irradiated for
4 min in a domestic microwave oven operating at 600 W and frequency 14545 Hz. The average optimum
time of reactionwas initially studied to obtain themost appropriate time required for the complete reaction.
Hence, reaction was left to progress for 5 min and product checked on the thin layer chromatography
thereafter. The resultingmixture was chromatographed on silica gel and elutedwith n-hexane yielding 3.5 g
of compound 2 (Fig. 2): (E)-ethyl 3-(4-hydroxy-3-methoxyphenyl)acryloylcarbamate. Brown liquid (Yield:
51%). IR (KBr): vmax (cm
−1) 3508–3300 (OH, NH), 3086 (Ar C-H), 2958–2858 (CH), 1815 (C = O), 1606
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(C = C), 1238 (C-O). 1H NMR (300 MHz, MeOD): δH 7.8 (s, 1H, NH), 7.00 (dd, 2H), 6.67 (d, 1H, JHH 8.1,
Hortho), 6.65 (d, 1H, JHH 8.1, Hortho), 6.66 (s, 1H, Ar-OH), 4.82 (s, 1H, Ar-OH), 3.84 (s, 3H, OCH3), 3.30 (m,
2H), 1.51 (t, 3H). 13 C NMR (75 MHz, MeOD): δC 148.9, 148.3, 147.5, 137.9, 129.3, 120.8, 116.1, 116.0,
111.3, 110.2, 56.4, 56.3, 19.46. ESI-MS; m/z: 283.08 (M + 18) + observed for C13H15NO5.
In vitro antioxidant screening
Superoxide anion scavenging assay
This was performed according to the method described by Luo et al.[27] Briefly, 1 ml of FA or its
derivatives was added to 4.5 ml of Tris-HCl buffer. After 20 min-incubation at 25°C, pyrogallol
(25 mmol) was added and the reaction terminated after 4 min with HCl solution (8 mol/L). The
mixture was centrifuged at 1000 g (Uniscope Laboratory Centrifuge SM800B, Surgifriend Medicals,
UK) for 15 min, and the absorbance reading was recorded at 325 nm (Jenway UV/Vis spectro-
photometer, Staffordshire, UK). The percentage of scavenging activity was estimated as follows:
% activity ¼ AoAs=Aoð Þ 100
Figure 1. Schematic for synthesis of ferulic acid (FA)—Syringaldehyde ester (Compound 1). FA (2.0 g, 10 mmol) and syringalde-
hyde (3.0 g, 16 mmol) with 2 drops of sulfuric acid were refluxed in 40 ml of DMSO for 3 h. The progress of the reaction was
monitored by thin layer chromatography, and it was stopped when there was no sign of any further reaction taking place. The
resulting mixture was chromatographed on silica gel (hexane-dichloromethane, 1:1) to afford 3.2 g of compound 1: (E)-4-formyl-
2,6-dimethoxyphenyl 3-(4-hydroxy-3-methoxyphenyl)acrylate. Brown liquid (Yield: 87%). IR (KBr): vmax (cm
−1) 3450 (OH), 3005 (Ar
C-H), 2958–2858 (CH), 1693 (C = O), 1593 (C = C), 1236 (C-O). 1H NMR (300 MHz, CDCl3): δH 9.87 (s, 1H), 7.83 (d, 1H), 7.24 (s, 1H),
7.24 (s, 1H), 7.13 (s, 1H), 6.95 (s, 1H), 6.87 (d, 1H), 6.87 (s, 1H), 6.76 (d, 1H), 5.23 (ArOH), 3.92 (s,3H, OCH3), 3.89 (s, 6H, 2 OCH3). 13 C
NMR (75 MHz, CDCl3): δC 191.1, 154.4, 146.8, 146.7, 145.9, 144.9, 140.1, 137.9, 137.8, 136.8, 126.4, 120.4, 120.2, 114.6, 114.1, 111.7,
56.3, 56.0, 55.9. ESI-MS; m/z: 376.86 (M + 18) + observed for C19H18O7.
Figure 2. Schematic for synthesis of FA—Urethane Amide (Compound 2). FA (5.0 g, 25 mmol) and urethane (10.0 g, 112 mmol)
with catalytic amount of imidazole were irradiated for 4 min in a domestic microwave oven operating at 600 W and frequency
14545 Hz. The average optimum time of reaction was initially studied to obtain the most appropriate time required for the
complete reaction. Hence, reaction was left to progress for 5 min and product checked on the thin layer chromatography
thereafter. The resulting mixture was chromatographed on silica gel and eluted with n-hexane to afford 3.5 g of compound 2: (E)-
ethyl 3-(4-hydroxy-3-methoxyphenyl)acryloylcarbamate. Brown liquid (Yield: 51%). IR (KBr): vmax (cm
−1) 3508–3300 (OH, NH), 3086
(Ar C-H), 2958–2858 (CH), 1815 (C = O), 1606 (C = C), 1238 (C-O). 1H NMR (300 MHz, MeOD): δH 7.8 (s, 1H, NH), 7.00 (dd, 2H), 6.67
(d, 1H, JHH 8.1, Hortho), 6.65 (d, 1H, JHH 8.1, Hortho), 6.66 (s, 1H, Ar-OH), 4.82 (s, 1H, Ar-OH), 3.84 (s, 3H, OCH3), 3.30 (m, 2H), 1.51 (t,
3H). 13 C NMR (75 MHz, MeOD): δC 148.9, 148.3, 147.5, 137.9, 129.3, 120.8, 116.1, 116.0, 111.3, 110.2, 56.4, 56.3, 19.46. ESI-MS; m/z:
283.08 (M + 18) + observed for C13H15NO5.
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where Ao: absorbance without sample; As: absorbance with sample.
Hydroxyl radical scavenging assay
This assay was performed according to the method described by Luo et al.[27] Briefly, 1 ml of FA or
its derivatives was incubated with 2 mM EDTA-Fe (0.5 ml), 3% H2O2 (1 ml) in 4.5 ml sodium
phosphate buffer (150 mM, pH 7.4) for 30 min. Hydroxyl radical was detected by recording the
absorbance at 520 nm (Jenway UV/Vis spectrophotometer, Staffordshire, UK). Scavenging activity
was estimated as follows:
Radical scavenging effect %ð Þ¼ AoAs=Aoð Þ x 100
where Ao: absorbance of control; As: absorbance of sample.
Ferric reducing antioxidant power assay
This assay was performed according to the method described by Benzie and Strain.[29] Briefly, an
aliquot of FA or its derivatives was added to a mixture of sodium phosphate buffer (200 mM)
containing 1% potassium ferricyanide. After 20 min-incubation at 50°C, 10% TCA was added and
the mixture was centrifuged at 650 g for 10 min (Uniscope Laboratory Centrifuge SM800B,
Surgifriend Medicals, UK). The supernatant was collected, mixed with equal volume of ddH2O
and added to 0.1% ferric chloride. The absorbance of mixture was recorded at 700 nm (Jenway UV/
Vis spectrophotometer, Staffordshire, UK) against blank (ddH2O). L-ascorbic acid was used as
standard reference. A higher absorbance indicates a higher reducing power.
Scavenging assay for 2,2, diphenyl-1-picrazyl hydrazyl radical
This assay was performed according to the method described by Devi et al.[30] Briefly, an aliquot of
FA or its derivatives was added to DPPH-methanol (0.1 mM) solution. After 30 min-incubation at
25°C in the dark, decrease in absorbance was recorded at 517 nm (Jenway UV/Vis spectrophot-
ometer, Staffordshire, UK). Methanol plus DPPH without FA was used as the positive control, while
the blank contained only methanol without DPPH. Percentage activity was estimated as:
% activity ¼ 1 f absorbance of sample absorbance of blankð Þ=absorbance of controlg½  x 100
Nitrogen radical species scavenging assay
This assay was performed according to the method described by Ilavarasan et al.[31] Briefly, equal volumes
of the FA or its derivatives and sodium nitroprusside weremixed. After 5 h-incubation at 25°C, themixture
was diluted with Greiss reagent (1:1 v/v). The absorbance of mixture was recorded at 546 nm (Jenway UV/
Vis spectrophotometer, Staffordshire, UK). Activity was estimated as:
% activity ¼ 100= blank absorbance x sample absorbanceð Þ½ 
Deoxyribose degradation inhibitory potential (specific and non-specific)
This assay was performed according to the method described by Lee et al.[32] For non-specific activity,
aliquot of FA or its derivatives was added to a reaction buffer (100 µM FeC2l3, 104 µM EDTA, 1.5 mM
H2O2, 2.5 mM deoxyribose and 100 µM ascorbic acid, pH 7.4). After 1 h-incubation at 37°C, 0.5% TBA in
0.025MNaOH and 2.8% TCAwere added to the mixture and heated for 30 min at 80°C. The mixture was
cooled on ice and absorbance recorded at 532 nm (Jenway UV/Vis spectrophotometer, Staffordshire, UK).
For site-specific activity (which represents ability of FA or its derivatives to directly chelate iron ions
and interfere with hydroxyl generation), the same procedure was repeated but without the EDTA.
Activity was estimated as:
% activity ¼ 1 sampleAbs=control Absð Þ½  x 100:
where Abs: Absorbance.
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Total antioxidant capacity
The assay was performed according to Saha et al.[33] Briefly, an aliquot of FA or its derivatives was
added to a reagent solution (0.6 M sulfuric acid, 28 mM sodium phosphate, and 4 mM ammonium
molybdate). After 90 min-incubation at 95°C, the mixture was cooled to room temperature and the
absorbance recorded at 695 nm (Jenway UV/Vis spectrophotometer, Staffordshire, UK) against the
blank. Methanol was used as the blank. The activity was expressed as the number of gram
equivalents of ascorbic acid.
Membrane stabilizing effect
The assay was performed as described by Malomo et al.[34] The assay mixture consisted of PBS,
indomethacin (reference drug) or different concentrations of FA or its derivatives, and 2% erythrocyte
suspension in isosaline. The control was prepared without the reference drug (or FA/derivatives)
whereas the drug control and the FA control lacked erythrocyte suspension. After 30 min-incubation
at 56°C, the mixture was cooled and centrifuged at 1000× g (Uniscope Laboratory Centrifuge SM800B,
Surgifriend Medicals, UK) for 15 min. The absorbance of the supernatant was recorded at 560 nm
(Jenway UV/Vis spectrophotometer, Staffordshire, UK). The activity was estimated as:
%membrane stabilizing activity ¼ 100 x f Drug test value Drug control valueð Þ=Control valueg½ 
Metal-chelating activity
The assay was performed according to Devi et al.[30] Briefly, aliquot of FA or its derivatives was
added to FeCl2. The reaction was initiated by adding ferrozine followed by methanol with vigorous
shaking. After 10 min-incubation at room temperature, the absorbance of the mixture was recorded
at 562 nm (Jenway UV/Vis spectrophotometer, Staffordshire, UK). The activity was estimated as:
% activity ¼ 1 As=Acð Þ½  x 100
where As: absorbance of sample; Ac: absorbance of control.
Preparation of liver homogenate
Apparently, healthy adult Wistar rats were sourced from the small Animal House, Department of
Biological Sciences, Landmark University, Omu Aran, Kwara State. Liver samples were excised into
ice-cold isotonic solution (0.15 M KCl), weighed, and homogenized. The homogenate was centri-
fuged at 5000 × g for 10 min using a refrigerated centrifuge (Anke TDL-5000B, Shanghai, China).
The supernatant was collected and used for further biochemical analyses.
Inhibition of lipid peroxidation in rat liver homogenate
Assay for in vitro lipid peroxidation of liver homogenate was carried out according to the procedure
described by Okhawa et al.[35] Briefly, aliquots of liver homogenate in KCl (10% w/v) were taken in
different test tubes and the test compounds (FA/FA derivatives or ascorbic acid; concentration range
1–10 mg/ml) and 15 mM FeSO4 were added. After 30 min-incubation at 37°C on a shaker, aliquot of
the mixture was added to TBA in 50% acetic acid and then heated in a water bath at 85°C for 30 min.
The reaction was stopped by adding equal volumes of TCA. The mixture was centrifuged at 1500 × g
(Anke TDL-5000B, Shanghai, China) for 10 min, and the absorbance was recorded at 535 nm (UV/
VIS spectrophotometer, Jenway, Staffordshire, UK). The inhibiting activity was estimated as: %
Inhibition = [(Control – Test) × 100]/Control
Computational docking studies
Dataset
The X-ray crystal structures of the molecular targets along with their respective ligands were
downloaded from the Protein Data Bank. The dataset was structurally processed using Discovery
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Studio, software version 4.1.[36] In this study, we have used two proteins which included; [1] Vanin-
1: a key enzyme which links metabolic disease and inflammation (PDB ID: 4CY) along with its
original ligand (2R)-2,4-dihydroxy-N-[(3S)-3-hydroxy-4-phenylbutyl]-3, 3-dimethylbutanamide. [2]
estrogen receptor in complex with its original ligand 2-phenyl-1-[4-(2-piperidin-1-YL-ethoxy)-phe-
nyl]-1,2,3,4-tetrahydro-isoquinolin-6-ol (PDB ID: 1UOM).
Computational docking protocol
In order to predict the possible molecular mechanism involved, molecular docking was conducted
using the three-dimensional X-ray crystals pre-processed and curated (e.g., removal of water,
addition of explicit hydrogen) using the Protein Preparation Wizard from the Gold Suite.[37] The
histidine protonation states were determined and fixed in the protein structures. Binding site was
determined using the prior knowledge of the original ligand interaction site for the respective
protein structures. GoldScore was used as the scoring function to rank docked compounds.
However, scores were not considered for final pose selections. In the docking simulation process,
each ligand was kept flexible but the amino acid residues of the proteins were held rigid. The
selection of atoms in the active site within 6 A or original ligand was chosen. The number of best
generated pose was set to 10.
Data analysis
Data were analyzed using the one-way ANOVA (GraphPad Software Inc., San Diego, CA) and
presented as the mean ± SEM. Difference among the group means was determined by the Tukey’s
test. Mean values at p < 0.05 were considered to be significant.
Results
Synthesis of (E)-4-formyl-2,6-dimethoxyphenyl 3-(4-hydroxy-3-methoxyphenyl)acrylate[1]
The synthesis of 1 was carried out in the presence of DMSO and sulfuric acid using a classical
method of refluxing to afford 87% yield of the brown liquid product. The reaction product was
purified via gravity column chromatography on silica gel using hexane-dichloromethane at 1:1. The
reaction which gave an indication of the formation of the product was monitored by the TLC and
was terminated as soon as no further reaction was observed. The FTIR indicated the presence of all
necessary peaks while the disappearance of the carboxylic proton signal of the FA confirms a
successful reaction. The molecular weight of the water adduct of the product was confirmed at m/
z 376.
Synthesis of (E)-ethyl 3-(4-hydroxy-3-methoxyphenyl)acryloylcarbamate[2]
The synthesis of 2 was attained via microwave assisted approach to afford 51% of the product. The
condensation reaction was accomplished using imidazole as catalyst and the product purified using
column chromatography packed with silica gel and eluted with n-hexane. The product indicated the
presence of N-H stretching vibration at 3508 to confirm a successful condensation. The NMR
showed all corresponding signals while the mass spectrum also showed the molecular ion peak as
water adduct at m/z 283.
In vitro antioxidant assays
The FA ester and amide derivatives showed strong protective potential against the hydroxyl-
induced deoxyribose degradation both in the site specific and non-site specific assays. The average
protective activity of the FA derivatives is > 60% and compares favorably with those of FA and
ascorbic acid (Fig. 3a–b). The FA ester and amide derivatives showed appreciable iron-chelating
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potential similar to those of the reference compounds, FA, and ascorbic acid (Fig. 4a). The FA
ester showed zero scavenging activity against superoxide radicals at the doses tested. In contrast,
FA amide showed scavenging activity similar to those of FA and ascorbic acid (Fig. 4b). The FA
amide showed no scavenging activity for hydroxyl radical while the FA ester had scavenging
potential higher than those of the FA and ascorbic acid (Fig. 4c).
The FA ester and amide derivatives appreciably scavenged the reactive nitrogen radicals with
capacity similar to those of the FA and ascorbic acids (Fig. 5a). The FA ester and amide derivatives
showed appreciable DPPH radical scavenging potential which appeared concentration dependent.
The scavenging activity of the FA derivatives compare favorably with those of the FA and ascorbic
acid (Fig. 5b). The FA ester derivative showed superior ferric reducing antioxidant capacity relative
to the FA, ascorbic acid, and/or FA amide derivative (Fig. 5c).
The FA ester and amide derivatives had higher total antioxidant capacity (expressed as equivalent of
ascorbic acid) relative to FA (Fig. 6a). The FA ester and amide derivatives showed strong membrane-
protective effect which increased with rising concentration. Similarly, FA and ascorbic acid demon-
strated membrane-protective potential (Fig. 6b). The FA ester and amide derivatives demonstrated
appreciable protection against iron-induced lipid peroxidation of liver homogenate. The protective
activity of the FA derivatives compares well with those of the FA and ascorbic acid (Fig. 6c).
Figure 3. Inhibitory potential of ferulic ester and amide derivatives against degradation of deoxyribose: (A) non-specific inhibition;
(B) specific inhibition. Data are presented as mean ± standard error of mean (SEM), n = 3.
Figure 4. Activity of ferulic ester and amide derivatives. (A) Metal chelating. (B) Superoxide anion scavenging. (C) Hydroxyl radical
scavenging. Data are presented as mean ± SEM, n = 3.
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Computational docking analysis
Molecular docking poses were analyzed based on the best orientation and interaction of the ligand
with respect to the molecular receptor as well as docking scores. However, preferences were given on
the binding interactions over the docking scores. A hierarchical clustering was computed using root-
Figure 5. Protective activity of ferulic ester and amide derivatives against (A) peroxynitrite radical; (B) DPPH radical; (C) FRAP. Data
are presented as mean ± SEM, n = 3.
Figure 6. Total antioxidant and protective capacity of ferulic ester and amide derivatives: (A) total antioxidant capacity (TAC); (B)
membrane stabilizing; (C) lipid peroxidation. Data are presented as mean ± SEM, n = 3.
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mean-square deviation between coordinates of all poses of each compound. The largest cluster at a
clustering distance of 3 Å was investigated further. With the chosen settings, it was possible to re-
dock the original ligands into a similar orientation of their respective molecular receptors. Analysis
of molecular docking indicated ferulic ester as potent inhibitor of target proteins in breast cancer as
well as in oxidative stress (Figs. 7–10).
Discussion
Research efforts to maximize the therapeutic benefits of FA have led to the synthesis of several
derivatives with enhanced physico-chemical and antioxidant property.[14,15] For example, the ester-
ification of FA has been employed to increase its effectiveness.[23] In the present study, we provide
comparative evaluation of the antioxidant activities of FA and its amide and ester derivatives.
The FA ester and amide derivatives as well as the FA showed significant levels of protection
against deoxyribose site specific and non-site specific degradation. This may be due to the phenolic
groups present in their structures. The findings are consistent with a previous study which showed
that FA and its derivatives protected against deoxyribose degradation.[6] The protection against
deoxyribose degradation afforded by FA as well as the FA ester and amide derivatives may suggest
potential to protect the DNA against reactive oxygen species-induced damage. Also, the FA as well as
Figure 7. Computational prediction of binding mode: (A) original ligand (pink); (B) FA ester derivative (green) docked in the crystal
structure of the breast cancer protein (cyan).
Figure 8. Interaction between receptor side chains and docked ligand. (A) Binding mode interactions of the original ligand with
the receptor (Pdb Code: 1UOM), the ligand binds to the receptor residues GLU353, ARG 394 of chain A. (B) Binding mode
interactions of the FA ester derivative the receptor (Pdb Code: 1UOM). The ligand binds to the receptor residues ARG 394, HIS524
of chain A. The ligand-interaction plots were generated using Discovery Studio (Acceryls Software, Inc).
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the FA ester and amide derivatives demonstrated potential to chelate iron. Though the iron-chelating
capacity of FA as demonstrated in the present study does not conform with a previous study,[38] FA
was reported to lack Fe2+ and Cu2+ chelating activity. The reason for the contrasting result is not
known but may not be unconnected with the assay procedure. Nevertheless, the iron- or metal-
chelating potential of the FA and FA ester and amide derivatives could serve to boost their
antioxidant capacity where appropriate. For example, in the present study, the metal-chelating
potential may be linked to higher total antioxidant capacity by the FA ester and amide derivatives.
Meanwhile, the capacity of FA to scavenge nitrogen reactive species is consistent with a previous
report by Ogiwara et al.[39] which investigated the antioxidant potential of FA.
Furthermore, the FA ester and amide derivatives showed appreciable DPPH radical scavenging
potential which was concentration dependent. A previous study[25] showed that FA was more
effective than its derivatives in scavenging DPPH radicals. However, in the present study, the
DPPH scavenging activity does not appear to be higher than those of FA ester and amide derivatives.
This is consistent with findings by Naik et al.[40] The FA ester derivative showed superior ferric
reducing antioxidant capacity relative to the FA, ascorbic acid, and/or FA amide derivative. The FA
ester and amide derivatives showed good membrane-protective effect which appear to be dose-
dependent. The membrane-stabilizing effect may indicate potential for anti-inflammatory potential.
Moreover, the ability of a compound to inhibit lipid peroxidation may be an indicator of antioxidant
Figure 9. Computational prediction of binding mode: (A) original ligand shown in (cyan); (B) FA ester derivative shown (green)
docked in the crystal structure of the oxidative stress protein (pink).
Figure 10. Interaction between receptor side chains and docked ligand. (A) Binding mode interactions of the original ligand with
the receptor (Pdb Code: 4CYG), the ligand binds to the receptor residues CYS211, LYS178, GLU390 of chain A. (B) Binding mode
interactions of the FA ester derivative the receptor (Pdb Code: 4CYG). The ligand binds to the receptor residues CYS211, LYS178,
PHE212, and LYS272 of chain A. The ligand-interaction plots were generated using Discovery Studio (Acceryls Software, Inc).
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potential. FA ester and amide derivatives strongly inhibited ferrous-induced lipid peroxidation, thus
implying that FA derivatives have potent antioxidant properties similar to those of the parent
compound FA. This is consistent with previous findings.[5] Furthermore, the capacity of the FA
ester and amide derivatives to inhibit lipid peroxidation underscores its membrane-protecting
activity. Taken together, our findings are consistent with investigations which have linked lipophilic
character of FA derivatives to higher antioxidant property.[25,26] For example, the addition of ethyl
groups makes FA more lipophilic, increasing the ability of the derivative to cross lipid-rich cell
membranes. The increased lipophilicity may underscore a better antioxidant potential as the
membranes such as the blood–brain barrier become more permeable and accessible. Furthermore,
the molecular docking analysis indicated ferulic ester as potent inhibitor of target proteins in breast
cancer as well as in oxidative stress, thus providing additional evidence in support of the medicinal
prospects of the FA derivatives.
Conclusion
Data obtained in this study indicated that strategic modification of FA did not significantly affect its
antioxidant activity, thus implying that FA ester and amide derivatives may possess much better
antioxidant activities compared with the parent compound. The findings of this study may find
relevance in cases where structural modification of FA for physico-chemical purposes as well as the
preservation of the antioxidant potential is expedient.
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